Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apo E variants in patients with type III hyperlipoproteinemia.

Atherosclerosis - 20 Dec 1996

Civeira F, Pocoví M, Cenarro A, Casao E, Vilella E, Joven J, González J, Garcia-Otín A L, Ordovás J M

Abstract excerpt

Type III hyperlipoproteinemia (HLP III) is characterized by the reduced catabolism and accumulation of chylomicron and very low density lipoprotein (VLDL) remnants. Most HLP III patients are homozygous for the apolipoprotein E2 (Cys112, Cys158) allele; however, several other mutations at this gene locus have been associated with this HLP. In order to assess the presence of rare apo E variants in our population,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Probes

Share to Genotype

Share to Phenotype

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 9125318
DOI: 10.1016/s0021-9150(96)05969-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apo E variants in patients with type III hyperlipoproteinemia.PMID 9125318Read ↗

Molecular basis of type III hyperlipoproteinemia in Germany.Semantic proximity Read ↗

Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.Semantic proximity Read ↗

Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.Semantic proximity Read ↗

The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.Semantic proximity Read ↗

Rare apolipoprotein E variant identified in a patient with type III hyperlipidaemia.Semantic proximity Read ↗

Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.Semantic proximity Read ↗

Identification of a new apolipoprotein E variant (E2 Arg142-->Leu) in type III hyperlipidemia.Semantic proximity Read ↗

The Apolipoprotein E2(Arg145Cys) Mutation Causes Autosomal Dominant Type III Hyperlipoproteinemia With Incomplete PenetranceSemantic proximity Read ↗

Apolipoprotein E genotypes of normal and hyperlipidemic subjects.Semantic proximity Read ↗

Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.Semantic proximity Read ↗

Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia.Semantic proximity Read ↗

Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.